Genetic testing company 23andMe has faced a series of struggles this year, culminating in end-of-year mass layoffs — 40% of ...

23andMe, the struggling ancestry tracing company, continues to spiral, raising questions about its business prospects and what could happen to its sensitive customer genetic testing data. CEO Anne ...

Meanwhile, Hims & Hers tackles the GLP-1 shortage with a new app; Eli Lilly releases data on tirzepatide efficacy; 23andMe faces privacy concerns; and more.

What is the most Silicon Valley thing about your morning routine? Zoë, you go first. Zoë Schiffer: Pretty much the first ...

But it’s not just staffing changes: 23andMe is also shutting down its entire therapeutics division, which had been working on ...

Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.

The genetic testing company 23andMe hasn't been doing so hot lately, watching its share price plummet more than 70% this year ...

and 23andMe has run out of runway: Substantial Doubt: Tuesday marked the fifth round of layoffs since the start of 2023, when ...

Home genetics company 23andMe continues to struggle as demand for casual gene tracing declines. On Monday, the company announced that it has decided on a restructuring ...

Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...

Me announced on Monday it would cut 40% of its workforce, representing more than 200 employees, as part of a restructuring at ...